Rare diseases
Investigational molecules
Locations
Back to Austria362 clinical trials in Innsbruck, Austria across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Letrozole Maintenance Therapy for Patients with Epithelial Ovarian Cancer
AustriaStudy on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib
AustriaStudy on the Effects of Ropivacaine and Lidocaine in Patients Receiving Cardiac Device Implants
AustriaStudy on the Effects of Ticagrelor and Acetylsalicylic Acid in Patients with Coronary Artery Disease Undergoing CABG Surgery
AustriaStudy on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination
AustriaAustriaStudy on the Effectiveness and Safety of Saruparib and Camizestrant in Adults with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
AustriaStudy on Atezolizumab and Bevacizumab for Patients with Intermediate-Stage Liver Cancer
AustriaStudy of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine
AustriaStudy on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination
AustriaStudy of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma
AustriaStudy on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment
AustriaThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on innovative treatments for various cancers, including bladder cancer, breast cancer, and gastric cancer. Studies evaluate novel combination therapies and targeted treatments to improve patient outcomes.
Research emphasizes personalized medicine approaches and innovative drug combinations.
Groundbreaking studies examining treatments for multiple sclerosis and other neurological conditions. Research focuses on testing new therapeutic agents and evaluating their effectiveness in managing disease progression.
Trials aim to advance understanding of disease mechanisms and improve treatment outcomes.
Clinical investigations into chronic inflammatory diseases, including Crohn's Disease and ulcerative colitis. Studies evaluate novel therapeutic approaches and combination treatments.
Research focuses on improving quality of life for patients with chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
